Recursion Pharmaceuticals (RXRX) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Recursion Pharmaceuticals (RXRX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 6.47M (-81.80%) | 36M (+586.10%) | 5.18M (-73.05%) | 19M (+30.31%) | 15M (+224.18%) | 4.55M (-82.55%) | 26M (+80.86%) | 14M (+4.57%) | 14M (+26.63%) | 11M (+3.42%) | 11M (-4.45%) | 11M (-9.15%) | 12M (-11.33%) | 14M (+3.95%) | 13M (+71.58%) | 7.67M (+43.90%) | 5.33M (+110.67%) | 2.53M (0.00%) | 2.53M (-0.78%) | 2.55M (-0.39%) | 2.56M (-4.83%) | 2.69M (+163.73%) | 1.02M (+436.84%) | 190K (+216.67%) | 60K |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 88M (-8.38%) | 96M (-20.75%) | 121M (-5.89%) | 129M (-0.76%) | 130M (+31.83%) | 98M (+31.81%) | 75M (+0.91%) | 74M (+9.43%) | 68M (-2.76%) | 69M (-0.76%) | 70M (+27.15%) | 55M (+17.95%) | 47M (+6.14%) | 44M (+7.69%) | 41M (+6.24%) | 38M (+18.50%) | 32M (-32.82%) | 48M (+45.23%) | 33M (+12.26%) | 30M (+22.85%) | 24M (+16.47%) | 21M (+25.15%) | 17M (+24.92%) | 13M (+3.12%) | 13M |
Selling General And Administrative | 35M (+2.76%) | 34M (-19.14%) | 42M (-10.76%) | 47M (-14.64%) | 55M (-29.20%) | 77M (+104.42%) | 38M (+18.63%) | 32M (+1.34%) | 31M (+3.12%) | 30M (+4.32%) | 29M (+3.22%) | 28M (+23.70%) | 23M (+15.27%) | 20M (+1.80%) | 19M (-8.07%) | 21M (+0.62%) | 21M (+9.74%) | 19M (+22.37%) | 16M (+13.29%) | 14M (+54.92%) | 8.94M (+18.10%) | 7.57M (+8.76%) | 6.96M (+34.88%) | 5.16M (-7.19%) | 5.56M |
Operating Expenses | 135M (-6.18%) | 144M (-18.89%) | 177M (-9.25%) | 195M (-5.17%) | 206M (+9.45%) | 188M (+51.33%) | 124M (+8.25%) | 115M (+4.39%) | 110M (+0.28%) | 110M (-0.24%) | 110M (+18.71%) | 93M (+13.09%) | 82M (+9.83%) | 75M (-1.41%) | 76M (+2.53%) | 74M (+20.47%) | 61M (-9.16%) | 67M (+37.90%) | 49M (+12.56%) | 43M (+31.56%) | 33M (+16.91%) | 28M (+20.30%) | 24M (+27.72%) | 18M (0.00%) | 18M |
Depreciation And Amortization | 20M (-69.44%) | 64M | - | - | 19M (-8.04%) | 21M (+425.50%) | 4.00M (-2.44%) | 4.10M (-44.44%) | 7.38M (-40.82%) | 12M (+196.90%) | 4.20M (+5.00%) | 4.00M (+7.24%) | 3.73M (+10.03%) | 3.39M (+16.90%) | 2.90M (+7.41%) | 2.70M (-2.53%) | 2.77M (+31.90%) | 2.10M (-16.00%) | 2.50M (+4.17%) | 2.40M (+71.43%) | 1.40M (+53.85%) | 910K (-17.27%) | 1.10M (+10.00%) | 1.00M (+6.38%) | 940K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -128.50M (+18.62%) | -108.33M (-37.09%) | -172.20M (-2.29%) | -176.23M (-7.91%) | -191.37M (+4.14%) | -183.77M (+86.85%) | -98.35M (-2.18%) | -100.54M (+4.36%) | -96.34M (-2.62%) | -98.93M (-0.62%) | -99.55M (+21.83%) | -81.71M (+16.96%) | -69.86M (+14.56%) | -60.98M (-2.54%) | -62.57M (-5.47%) | -66.19M (+18.24%) | -55.98M (-13.82%) | -64.96M (+40.00%) | -46.40M (+13.36%) | -40.93M (+34.28%) | -30.48M (+19.16%) | -25.58M (+13.84%) | -22.47M (+23.33%) | -18.22M (-0.65%) | -18.34M |
Ebit | -128.50M (+18.62%) | -108.33M (-37.09%) | -172.20M (-2.29%) | -176.23M (-7.91%) | -191.37M (+4.14%) | -183.77M (+86.85%) | -98.35M (-2.18%) | -100.54M (+4.36%) | -96.34M (-2.62%) | -98.93M (-0.62%) | -99.55M (+21.83%) | -81.71M (+16.96%) | -69.86M (+14.56%) | -60.98M (-2.54%) | -62.57M (-5.47%) | -66.19M (+18.24%) | -55.98M (-13.82%) | -64.96M (+40.00%) | -46.40M (+13.36%) | -40.93M (+34.28%) | -30.48M (+19.16%) | -25.58M (+13.84%) | -22.47M (+23.33%) | -18.22M (-0.65%) | -18.34M |
EBITDA | -108.83M (+82.72%) | -59.56M (-63.10%) | -161.42M (-5.83%) | -171.42M (-0.36%) | -172.04M (+5.71%) | -162.75M (+72.50%) | -94.35M (-2.17%) | -96.44M (+8.41%) | -88.96M (+2.89%) | -86.46M (-9.32%) | -95.35M (+22.70%) | -77.71M (+17.49%) | -66.14M (+14.85%) | -57.59M (-3.49%) | -59.67M (-6.02%) | -63.49M (+19.32%) | -53.21M (-15.35%) | -62.86M (+43.19%) | -43.90M (+13.94%) | -38.53M (+32.50%) | -29.08M (+17.88%) | -24.67M (+15.44%) | -21.37M (+24.10%) | -17.22M (-1.09%) | -17.41M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Expense | 350K | -10.00K | 830K (+72.92%) | 480K (-5.88%) | 510K (-16.39%) | 610K (+10.91%) | 550K (+41.03%) | 390K (+1850.00%) | 20K (-33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (+50.00%) | 20K (+100.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | -20.00K | 220K (-91.20%) | 2.50M (+900.00%) | 250K (+8.70%) | 230K (-42.50%) | 400K (-6.98%) | 430K (+43.33%) | 300K |
Net Interest Income | - | - | - | - | - | 20K | - | - | -20.00K (-33.33%) | -30.00K (+50.00%) | -20.00K (-33.33%) | -30.00K (+50.00%) | -20.00K (+100.00%) | -10.00K (0.00%) | -10.00K (0.00%) | -10.00K (0.00%) | -10.00K | 20K | -220.00K (-91.20%) | -2.50M (+900.00%) | -250.00K (-52.83%) | -530.00K (+32.50%) | -400.00K (-6.98%) | -430.00K | - |
Other Non Operating Income | 6.40M (+97.53%) | 3.24M (-67.44%) | 9.95M (+129.79%) | 4.33M | -11.28M | 14M (+430.60%) | 2.68M (+8.06%) | 2.48M (-40.81%) | 4.19M (-76.63%) | 18M (+174.58%) | 6.53M (+30.86%) | 4.99M (+9.91%) | 4.54M (-27.36%) | 6.25M (+193.43%) | 2.13M (+238.10%) | 630K | - | -3.70M (+259.22%) | -1.03M (-58.30%) | -2.47M (+973.91%) | -230.00K (-90.38%) | -2.39M (+70.71%) | -1.40M (+91.78%) | -730.00K (+812.50%) | -80.00K |
Net Income | |||||||||||||||||||||||||
Income Before Tax | -122.11M (+12.96%) | -108.10M (-33.37%) | -162.25M (-5.61%) | -171.90M (-15.17%) | -202.64M (+13.27%) | -178.90M (+87.00%) | -95.67M (-2.44%) | -98.06M (+6.41%) | -92.15M (-5.06%) | -97.06M (+4.34%) | -93.02M (+21.23%) | -76.73M (+17.45%) | -65.33M (-72.72%) | -239.48M | - | - | - | -186.48M | - | - | - | - | - | - | - |
Income Tax Expense | -4.60M | 20K | - | - | -160.00K | 10K (-94.12%) | 170K | -520.00K (-33.33%) | -780.00K (-80.79%) | -4.06M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -117.50M (+8.68%) | -108.12M (-33.36%) | -162.25M (-5.61%) | -171.90M (-15.11%) | -202.49M (+13.18%) | -178.91M (+86.68%) | -95.84M (-1.74%) | -97.54M (+6.75%) | -91.37M (-1.75%) | -93.00M (-0.02%) | -93.02M (+21.23%) | -76.73M (+17.45%) | -65.33M (+13.64%) | -57.49M (-4.88%) | -60.44M (-7.81%) | -65.56M (+17.11%) | -55.98M (-13.78%) | -64.93M (+36.90%) | -47.43M (+9.29%) | -43.40M (+41.28%) | -30.72M (+19.21%) | -25.77M (+7.96%) | -23.87M (+26.03%) | -18.94M (+2.82%) | -18.42M |
Net Income | -117.50M (+8.68%) | -108.12M (-33.36%) | -162.25M (-5.61%) | -171.90M (-15.11%) | -202.49M (+13.18%) | -178.91M (+86.68%) | -95.84M (-1.74%) | -97.54M (+6.75%) | -91.37M (-1.75%) | -93.00M (-0.02%) | -93.02M (+21.23%) | -76.73M (+17.45%) | -65.33M (+13.64%) | -57.49M (-4.88%) | -60.44M (-7.81%) | -65.56M (+17.11%) | -55.98M (-13.78%) | -64.93M (+36.90%) | -47.43M (+9.29%) | -43.40M (+41.28%) | -30.72M (+19.21%) | -25.77M (+7.96%) | -23.87M (+26.03%) | -18.94M (+2.82%) | -18.42M |
Comprehensive Income Net Of Tax | -127.56M (-78.75%) | -600.40M (+249.52%) | -171.78M (+20.62%) | -142.42M (-21.18%) | -180.70M (-61.66%) | -471.30M (+391.76%) | -95.84M (-1.74%) | -97.54M (+6.75%) | -91.37M (-72.15%) | -328.07M (+252.69%) | -93.02M (+21.23%) | -76.73M (+17.45%) | -65.33M (-72.71%) | -239.35M (+297.26%) | -60.25M (-7.94%) | -65.45M (+16.54%) | -56.16M (-69.90%) | -186.60M (+293.42%) | -47.43M (+9.29%) | -43.40M (+41.28%) | -30.72M (-64.69%) | -87.01M (+264.52%) | -23.87M | - | - |